HKPD · Cellyan Biotechnology Co., Ltd
$0.42
+0.05 (+14.11%)
At close · Jul 27
Market Cap
$9.79M
Shares
23.50M
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-18 | CHAN Kam Leung |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-18 | Wu Jingyan |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-18 | Liu Shu |
CFO |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-18 | Zhou Mike Yao |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-18 | Wang Zifeng |
Chief Strategy Officer |
Other↑
|
No Securities Owned
|
0 |
| 2026-03-18 | Liang Chenyu Andy |
Director, CEO and Director |
Other↑
|
No Securities Owned
|
0 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–6 of 6 transactions